Literature DB >> 22696628

Interferon-induced sarcoidosis.

Cláudia Cardoso1, Ricardo Freire, Ana Alves, Ana Oliveira.   

Abstract

Sarcoidosis is a rare side effect of interferon therapy that has been reported over the last years. We present the case of a 43-year-old man presenting with systemic sarcoidosis during treatment with pegylated interferon and ribavirin. Skin lesions, which were found to be associated with asymptomatic bilateral hilar lymph nodes and pulmonary nodules, were the sole clinical manifestation of the disease. Stopping therapy resulted in clinical and radiological improvement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22696628      PMCID: PMC3082057          DOI: 10.1136/bcr.03.2011.3929

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Interferon-induced sarcoidosis.

Authors:  S Alazemi; M A Campos
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

2.  Th1/Th2 cell distribution in pulmonary sarcoidosis.

Authors:  I Bäumer; G Zissel; M Schlaak; J Müller-Quernheim
Journal:  Am J Respir Cell Mol Biol       Date:  1997-02       Impact factor: 6.914

3.  Granulomatous and suppurative dermatitis at interferon alfa injection sites: report of 2 cases.

Authors:  Scott Sanders; Klaus Busam; Steven R Tahan; Richard A Johnson; Dana Sachs
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

Review 4.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 5.  Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.

Authors:  Manuel Ramos-Casals; Juan Mañá; Norma Nardi; Pilar Brito-Zerón; Antoni Xaubet; José Maria Sánchez-Tapias; Ricard Cervera; Josep Font
Journal:  Medicine (Baltimore)       Date:  2005-03       Impact factor: 1.889

6.  Sarcoidosis and interferon therapy: report of five cases and review of the literature.

Authors:  Stéphanie Leclerc; Robert P. Myers; Joseph Moussalli; Serge Herson; Thierry Poynard; Olivier Benveniste
Journal:  Eur J Intern Med       Date:  2003-07       Impact factor: 4.487

7.  Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma.

Authors:  E A Abdi; G K Nguyen; R N Ludwig; W J Dickout
Journal:  Cancer       Date:  1987-03-01       Impact factor: 6.860

Review 8.  Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature.

Authors:  Fabrizio Fantini; Claudia Padalino; Giulio Gualdi; Paola Monari; Alberto Giannetti
Journal:  Dermatol Ther       Date:  2009-11       Impact factor: 2.851

9.  Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients.

Authors:  Halil Yanardağ; Omer Nuri Pamuk; Tuncer Karayel
Journal:  Respir Med       Date:  2003-08       Impact factor: 3.415

Review 10.  Sarcoidosis: is therapy effective?

Authors:  R P Baughman; O P Sharma; J P Lynch
Journal:  Semin Respir Infect       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.